B. Acar Et Al. , "Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy," PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY , vol.46, no.3, pp.251-257, 2023
Acar, B. Et Al. 2023. Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY , vol.46, no.3 , 251-257.
Acar, B., Celikyurt, U., Agacdiken, A., & Vural, A., (2023). Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY , vol.46, no.3, 251-257.
Acar, BURAK Et Al. "Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy," PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY , vol.46, no.3, 251-257, 2023
Acar, BURAK Et Al. "Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy." PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY , vol.46, no.3, pp.251-257, 2023
Acar, B. Et Al. (2023) . "Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy." PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY , vol.46, no.3, pp.251-257.
@article{article, author={BURAK ACAR Et Al. }, title={Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy}, journal={PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY}, year=2023, pages={251-257} }